BigHat founder Mark DePristo spoke about “Antibody design using synthetic biology and machine learning at BigHat Biosciences” at SMI’s AI in Drug Discovery 2021 conference. Topics covered:
- An introduction to AI/ML in drug discovery
- An overview of the outstanding challenges in antibody design and engineering
- Integrating a high-speed wet lab and machine learning for antibody design and engineering
- Case studies of creating antibodies on BigHat's platform
Watch the talk on BigHat's YouTube channel or view the slides.
Posted:
4/8/2021
Read Time:
mins
Words by:
